Passage Bio, Inc. Common Stock
$5.945
USD
Last updated on --.
24h volume102.00
24h highest5.9950 USD
24h lowest5.9850 USD
24h Price movement-0.42%
PASG recent prices
24 Hours
-0.42%-$0.025
30 days
+39.23%+$1.675
60 days
-32.13%-$2.815
90 days
-29.23%-$2.455
Key data
Previous close5.9700 USD
Market cap18.51M USD
Volume102.00
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-11.7500 USD
Net income (FY)-37.68M USD
Revenue (FY)--
Last report dateMay 12, 2026
About Passage Bio, Inc. Common Stock
HeadquartersPHILADELPHIA
Employees (FY)24.00
Net income per employee (FY)-1.57M USD
Listed onNasdaq
PASG conversion tables
 |  |
|---|---|
| 0.5 PASG | 2.972 USD |
| 1 PASG | 5.945 USD |
| 5 PASG | 29.72 USD |
| 10 PASG | 59.45 USD |
| |
|---|---|
| 0.5 USD | 0.084104 PASG |
| 1 USD | 0.16821 PASG |
| 5 USD | 0.84104 PASG |
| 10 USD | 1.682 PASG |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PASG is trading at $5.945, -0.42% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PASG stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PASG is currently trading at $5.945, -0.42% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PASG price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PASG's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PASG; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PASG's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Passage Bio, Inc. Common Stock's market cap is currently 18.51M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume102.00
24h highest5.9950 USD
24h lowest5.9850 USD
24h Price movement-0.42%
Start trade with PASG Perpetual
Sign up to trade